/logo-16545883420.png){kind=logo}
Shenogen Presents at the ChinaBio Partnering Forum 2014
April 4th, 2014, Beijing
The ChinaBio Partnering Forum 2014 will be held on 7th-8th May in Suzhou, China. Dr. Jun Bao, Senior Vice President & Chief Business Officer of Shenogen Pharma Group, will give a presentation on behalf of Shenogen at the event. He plans to meet potential partners to collaborate with Shenogen at the conference. Dr. Bao will also serve as a panelist on the plenary panel “Innovation: The Evolution of R&D in Chinese Pharma”. ChinaBio Partnering Forum is the premier life science partnering event in China. Biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies will attend the two-day productive partnering event.
About Shenogen
Shenogen Pharma Group is a drug discovery and development company based in Beijing, China, that dedicated the development of first-in-class therapeutics for cancer treatment. We possess robust intellectual property rights around a novel membrane-bound estrogen receptor, ER-alpha 36, which is related to tumor metastasis. Under the motto of “Better Medicine, Better Life” and a seasoned management team, together with our partners, Shenogen has developed an impressive product pipeline. Our pipeline consists of novel small molecule and antibody therapeutics for cancer treatment which includes liver cancer, breast cancer, other solid tumors and leukemia. Our lead molecule, icaritin, is currently in Ph II clinical trial for treatment of advanced hepatocellular carcinoma.